Symbols / NVAX $10.24 -3.81%
NVAX Chart
About
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.67B |
| Enterprise Value | 1.28B | Income | 440.30M | Sales | 1.12B |
| Book/sh | -0.79 | Cash/sh | 4.51 | Dividend Yield | — |
| Payout | 0.00% | Employees | 749 | IPO | — |
| P/E | 3.97 | Forward P/E | -17.99 | PEG | — |
| P/S | 1.48 | P/B | -13.02 | P/C | — |
| EV/EBITDA | 2.16 | EV/Sales | 1.14 | Quick Ratio | 1.83 |
| Current Ratio | 2.13 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | 2.58 | EPS next Y | -0.57 | EPS Growth | — |
| Revenue Growth | 66.60% | Earnings | 2026-05-07 | ROA | 25.72% |
| ROE | — | ROIC | — | Gross Margin | 63.52% |
| Oper. Margin | 14.23% | Profit Margin | 39.19% | Shs Outstand | 162.94M |
| Shs Float | 140.49M | Short Float | 31.37% | Short Ratio | 10.16 |
| Short Interest | — | 52W High | 11.97 | 52W Low | 5.01 |
| Beta | 2.63 | Avg Volume | 5.09M | Volume | 1.58M |
| Target Price | $13.78 | Recom | Buy | Prev Close | $10.64 |
| Price | $10.23 | Change | -3.81% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$13.78
Mean price target
2. Current target
$10.25
Latest analyst target
3. DCF / Fair value
$-36.67
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.25
Low
$7.00
High
$25.00
Mean
$13.78
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-27 | main | HC Wainwright & Co. | Buy → Buy | $16 |
| 2026-01-20 | reit | BTIG | Buy → Buy | $19 |
| 2025-11-18 | main | JP Morgan | Underweight → Underweight | $6 |
| 2025-11-10 | reit | B. Riley Securities | Buy → Buy | $16 |
| 2025-11-04 | main | TD Cowen | Hold → Hold | $7 |
| 2025-10-24 | init | Cantor Fitzgerald | — → Overweight | $18 |
| 2025-10-23 | main | HC Wainwright & Co. | Buy → Buy | $11 |
| 2025-08-20 | down | B of A Securities | Neutral → Underperform | $7 |
| 2025-07-22 | main | B of A Securities | Neutral → Neutral | $9 |
| 2025-06-17 | init | Citigroup | — → Sell | $6 |
| 2025-05-09 | main | JP Morgan | Underweight → Underweight | $7 |
| 2024-12-10 | reit | HC Wainwright & Co. | Buy → Buy | $19 |
| 2024-11-13 | reit | HC Wainwright & Co. | Buy → Buy | $19 |
| 2024-11-12 | reit | HC Wainwright & Co. | Buy → Buy | $19 |
| 2024-08-12 | reit | B. Riley Securities | Buy → Buy | $23 |
| 2024-08-12 | main | JP Morgan | Underweight → Underweight | $9 |
| 2024-08-02 | main | B. Riley Securities | Buy → Buy | $25 |
| 2024-07-30 | down | JP Morgan | Neutral → Underweight | $8 |
| 2024-06-14 | main | B of A Securities | Neutral → Neutral | $18 |
| 2024-05-23 | main | B. Riley Securities | Buy → Buy | $29 |
- Why Is Novavax (NVAX) Stock Soaring Today - Yahoo Finance hu, 26 Feb 2026 08
- Here’s What You Should Understand Besides the Reason Novavax, Inc. (NVAX) is Gaining Attention - Bitget ue, 17 Mar 2026 15
- Novavax (NVAX) director John W. Shiver converts 7,947 RSUs into stock - Stock Titan hu, 12 Mar 2026 21
- Novavax (NASDAQ:NVAX) Stock Rating Upgraded by Wall Street Zen - MarketBeat Fri, 23 Jan 2026 08
- Novavax (NVAX) Turns Profitable With US$440 Million TTM Net Income Challenging Bearish Views - simplywall.st Fri, 27 Feb 2026 08
- BTIG Maintains a Buy Rating on Novavax (NVAX), Sets a $19 PT - MSN hu, 12 Mar 2026 22
- Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock - Yahoo Finance ue, 17 Mar 2026 13
- Novavax stock gains after Q4 revenue beat (NVAX:NASDAQ) - Seeking Alpha hu, 26 Feb 2026 08
- Novavax (NASDAQ:NVAX) Trading 7.6% Higher - Should You Buy? - MarketBeat ue, 17 Mar 2026 19
- Improved Revenues Required Before Novavax, Inc. (NASDAQ:NVAX) Stock's 32% Jump Looks Justified - simplywall.st Wed, 14 Jan 2026 08
- Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance Mon, 26 Jan 2026 08
- Farallon Capital Management LLC Purchases 764,000 Shares of Novavax, Inc. $NVAX - MarketBeat Mon, 16 Mar 2026 10
- How The Novavax (NVAX) Story Is Shifting Toward Licensing Income And COVID Recalibration - Yahoo Finance Sat, 28 Feb 2026 08
- Novavax (NASDAQ:NVAX) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened - MarketBeat hu, 12 Mar 2026 06
- Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - Yahoo Finance ue, 03 Mar 2026 08
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 7947 | — | — | SHIVER JOHN W. PH.D. | Director | — | 2026-03-10 00:00:00 | D | nan |
| 1 | 12223 | — | — | KELLY JAMES PATRICK | Chief Financial Officer | — | 2026-03-06 00:00:00 | D | nan |
| 2 | 37500 | — | — | CASEY MARK J | Officer | — | 2026-03-03 00:00:00 | D | nan |
| 3 | 43167 | — | — | KELLY JAMES PATRICK | Chief Financial Officer | — | 2026-03-03 00:00:00 | D | nan |
| 4 | 150167 | — | — | JACOBS JOHN C | Chief Executive Officer | — | 2026-03-03 00:00:00 | D | nan |
| 5 | 56334 | — | — | O'HARA ELAINE | Officer | — | 2026-03-03 00:00:00 | D | nan |
| 6 | 26667 | — | — | DRAGHIA-AKLI RUXANDRA | Officer | — | 2026-03-03 00:00:00 | D | nan |
| 7 | 4000 | — | — | CASEY MARK J | Officer | — | 2026-02-27 00:00:00 | D | nan |
| 8 | 58666 | — | — | KELLY JAMES PATRICK | Chief Financial Officer | — | 2026-02-27 00:00:00 | D | nan |
| 9 | 83333 | — | — | JACOBS JOHN C | Chief Executive Officer | — | 2026-02-27 00:00:00 | D | nan |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 10.91M | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.21 | 0.00 | 0.21 |
| NormalizedEBITDA | 618.89M | -159.99M | -487.39M | -604.71M |
| TotalUnusualItems | -126.56M | 51.95M | 0.00 | 0.00 |
| TotalUnusualItemsExcludingGoodwill | -126.56M | 51.95M | 0.00 | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | 440.30M | -187.50M | -545.06M | -657.94M |
| ReconciledDepreciation | 27.61M | 48.50M | 41.23M | 29.05M |
| ReconciledCostOfRevenue | 73.04M | 202.74M | 343.77M | 902.64M |
| EBITDA | 492.33M | -108.04M | -487.39M | -604.71M |
| EBIT | 464.71M | -156.54M | -528.62M | -633.77M |
| NetInterestIncome | -22.55M | -20.07M | -14.42M | -19.88M |
| InterestExpense | 22.55M | 20.07M | 14.42M | 19.88M |
| NormalizedIncome | 566.86M | -228.54M | -545.06M | -657.94M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 440.30M | -187.50M | -545.06M | -657.94M |
| TotalExpenses | 572.84M | 931.09M | 1.12B | 2.24B |
| TotalOperatingIncomeAsReported | 452.80M | -248.93M | -566.51M | -644.74M |
| DilutedAverageShares | 173.10M | 152.19M | 100.77M | 78.18M |
| BasicAverageShares | 161.99M | 152.19M | 100.77M | 78.18M |
| DilutedEPS | 2.58 | -1.23 | -5.41 | -8.42 |
| BasicEPS | 2.72 | -1.23 | -5.41 | -8.42 |
| DilutedNIAvailtoComStockholders | 445.74M | -187.50M | -545.06M | -657.94M |
| AverageDilutionEarnings | 5.44M | 0.00 | 0.00 | |
| NetIncomeCommonStockholders | 440.30M | -187.50M | -545.06M | -657.94M |
| NetIncome | 440.30M | -187.50M | -545.06M | -657.94M |
| NetIncomeIncludingNoncontrollingInterests | 440.30M | -187.50M | -545.06M | -657.94M |
| NetIncomeContinuousOperations | 440.30M | -187.50M | -545.06M | -657.94M |
| TaxProvision | 1.86M | 10.88M | 2.03M | 4.29M |
| PretaxIncome | 442.17M | -176.62M | -543.03M | -653.65M |
| OtherIncomeExpense | -85.93M | 92.39M | 37.90M | 10.97M |
| OtherNonOperatingIncomeExpenses | 40.63M | 40.44M | 37.90M | 10.97M |
| SpecialIncomeCharges | -126.56M | 51.95M | 0.00 | 0.00 |
| GainOnSaleOfPPE | 0.00 | 51.95M | 0.00 | 0.00 |
| OtherSpecialCharges | 28.71M | |||
| WriteOff | 97.84M | 0.00 | 0.00 | |
| GainOnSaleOfSecurity | 1.36M | |||
| NetNonOperatingInterestIncomeExpense | -22.55M | -20.07M | -14.42M | -19.88M |
| InterestExpenseNonOperating | 22.55M | 20.07M | 14.42M | 19.88M |
| OperatingIncome | 550.64M | -248.93M | -566.51M | -644.74M |
| OperatingExpense | 499.80M | 728.35M | 779.12M | 1.34B |
| OtherOperatingExpenses | -427.32M | -382.92M | -948.71M | |
| ResearchAndDevelopment | 342.32M | 391.17M | 737.50M | 1.24B |
| SellingGeneralAndAdministration | 157.48M | 337.19M | 468.95M | 488.69M |
| GeneralAndAdministrativeExpense | 488.69M | 298.36M | ||
| OtherGandA | 488.69M | 298.36M | ||
| GrossProfit | 1.05B | 479.42M | 212.61M | 696.31M |
| CostOfRevenue | 73.04M | 202.74M | 343.77M | 902.64M |
| TotalRevenue | 1.12B | 682.16M | 556.38M | 1.60B |
| OperatingRevenue | 1.12B | 682.16M | 556.38M | 1.60B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 2.39M | 1.52M | 1.00M | 766.63K |
| OrdinarySharesNumber | 162.58M | 160.42M | 139.51M | 86.04M |
| ShareIssued | 164.97M | 161.94M | 140.51M | 86.81M |
| NetDebt | 3.58M | |||
| TotalDebt | 248.81M | 230.42M | 229.08M | 549.78M |
| TangibleBookValue | -241.22M | -731.32M | -844.38M | -760.41M |
| InvestedCapital | 116.46M | -454.16M | -548.91M | -142.73M |
| WorkingCapital | 518.33M | -25.47M | -491.25M | -756.55M |
| NetTangibleAssets | -241.22M | -731.32M | -844.38M | -760.41M |
| CapitalLeaseObligations | 4.60M | 60.73M | 61.06M | 58.43M |
| CommonStockEquity | -127.75M | -623.84M | -716.93M | -634.08M |
| TotalCapitalization | 116.46M | -454.16M | -548.91M | -467.61M |
| TotalEquityGrossMinorityInterest | -127.75M | -623.84M | -716.93M | -634.08M |
| StockholdersEquity | -127.75M | -623.84M | -716.93M | -634.08M |
| GainsLossesNotAffectingRetainedEarnings | 2.01M | -22.56M | 2.72M | -6.38M |
| OtherEquityAdjustments | 2.01M | -22.56M | 2.72M | -6.38M |
| TreasuryStock | 103.02M | 95.85M | 92.27M | 90.66M |
| RetainedEarnings | -4.57B | -5.01B | -4.82B | -4.28B |
| AdditionalPaidInCapital | 4.54B | 4.50B | 4.19B | 3.74B |
| CapitalStock | 1.65M | 1.62M | 1.41M | 868.00K |
| CommonStock | 1.65M | 1.62M | 1.41M | 868.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | |
| TotalLiabilitiesNetMinorityInterest | 1.30B | 2.18B | 2.51B | 2.89B |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 844.32M | 1.03B | 879.28M | 432.81M |
| OtherNonCurrentLiabilities | 239.07M | 359.61M | 33.13M | 55.70M |
| PreferredSecuritiesOutsideStockEquity | 0.00 | 0.00 | 0.00 | 0.00 |
| NonCurrentDeferredLiabilities | 358.94M | 446.82M | 622.21M | 179.41M |
| NonCurrentDeferredRevenue | 358.94M | 446.82M | 622.21M | 179.41M |
| LongTermDebtAndCapitalLeaseObligation | 246.30M | 223.41M | 223.94M | 197.70M |
| LongTermCapitalLeaseObligation | 2.09M | 53.73M | 55.92M | 31.24M |
| LongTermDebt | 244.21M | 169.68M | 168.02M | 166.47M |
| CurrentLiabilities | 459.95M | 1.15B | 1.64B | 2.46B |
| OtherCurrentLiabilities | 185.65M | 219.60M | 861.41M | 930.05M |
| CurrentDeferredLiabilities | 140.05M | 675.07M | 241.31M | 370.14M |
| CurrentDeferredRevenue | 140.05M | 675.07M | 241.31M | 370.14M |
| CurrentDebtAndCapitalLeaseObligation | 2.51M | 7.01M | 5.14M | 352.08M |
| CurrentCapitalLeaseObligation | 2.51M | 7.01M | 5.14M | 27.20M |
| CurrentDebt | 324.88M | |||
| OtherCurrentBorrowings | 324.88M | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 50.98M | 60.35M | 55.95M | 52.57M |
| PayablesAndAccruedExpenses | 80.77M | 192.39M | 471.33M | 755.11M |
| CurrentAccruedExpenses | 56.19M | 150.81M | 338.72M | 538.59M |
| Payables | 24.58M | 41.58M | 132.61M | 216.52M |
| AccountsPayable | 24.58M | 41.58M | 132.61M | 216.52M |
| TotalAssets | 1.18B | 1.56B | 1.80B | 2.26B |
| TotalNonCurrentAssets | 198.24M | 431.48M | 653.60M | 555.29M |
| OtherNonCurrentAssets | 17.08M | 24.00M | 35.16M | 28.47M |
| GoodwillAndOtherIntangibleAssets | 113.46M | 107.48M | 127.45M | 126.33M |
| OtherIntangibleAssets | 4.77M | |||
| Goodwill | 113.46M | 107.48M | 127.45M | 126.33M |
| NetPPE | 67.70M | 300.00M | 490.99M | 400.49M |
| AccumulatedDepreciation | -40.62M | -49.16M | -74.97M | -47.29M |
| GrossPPE | 108.32M | 349.15M | 565.96M | 447.78M |
| Leases | 31.25M | 66.89M | 48.31M | 18.89M |
| ConstructionInProgress | 6.27M | 39.51M | 76.16M | 81.57M |
| OtherProperties | 22.90M | 161.59M | 185.22M | 106.24M |
| MachineryFurnitureEquipment | 47.90M | 66.23M | 153.36M | 139.74M |
| LandAndImprovements | 0.00 | 14.95M | 102.92M | 101.34M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 978.28M | 1.13B | 1.14B | 1.70B |
| OtherCurrentAssets | 9.87M | 21.89M | 155.73M | 76.37M |
| AssetsHeldForSaleCurrent | 87.51M | 0.00 | ||
| RestrictedCash | 10.88M | 10.63M | 10.42M | 10.30M |
| PrepaidAssets | 16.95M | 56.28M | 70.30M | 160.77M |
| Inventory | 11.54M | 8.75M | 41.70M | 36.68M |
| FinishedGoods | 1.34M | 1.76M | 27.69M | 1.36M |
| WorkInProcess | 7.59M | 4.90M | 7.39M | 21.41M |
| RawMaterials | 2.61M | 2.09M | 6.61M | 13.91M |
| Receivables | 106.45M | 108.28M | 297.24M | 82.38M |
| AccountsReceivable | 106.45M | 108.28M | 297.24M | 82.38M |
| CashCashEquivalentsAndShortTermInvestments | 735.08M | 923.12M | 568.50M | 1.34B |
| OtherShortTermInvestments | 494.45M | 392.89M | 0.00 | 0.00 |
| CashAndCashEquivalents | 240.63M | 530.23M | 568.50M | 1.34B |
| CashEquivalents | 1.42B | |||
| CashFinancial | 96.37M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -251.02M | -101.90M | -772.77M | -508.92M |
| RepaymentOfDebt | -10.07M | -3.99M | -352.35M | -93.59M |
| IssuanceOfDebt | 42.61M | 0.00 | 0.00 | 175.25M |
| IssuanceOfCapitalStock | 0.00 | 263.27M | 360.24M | 249.23M |
| CapitalExpenditure | -6.39M | -14.64M | -58.81M | -92.98M |
| InterestPaidSupplementalData | 15.05M | 17.57M | 17.35M | 18.04M |
| IncomeTaxPaidSupplementalData | 8.81M | 949.00K | 190.00K | 17.98M |
| EndCashPosition | 256.05M | 545.29M | 583.81M | 1.35B |
| BeginningCashPosition | 545.29M | 583.81M | 1.35B | 1.53B |
| EffectOfExchangeRateChanges | 5.92M | -7.80M | 3.27M | 4.52M |
| ChangesInCash | -295.17M | -30.72M | -768.31M | -183.93M |
| FinancingCashFlow | 27.74M | 260.58M | 4.47M | 324.99M |
| CashFlowFromContinuingFinancingActivities | 27.74M | 260.58M | 4.47M | 324.99M |
| NetOtherFinancingCharges | -3.59M | -5.26M | ||
| ProceedsFromStockOptionExercised | -4.80M | 1.30M | 159.00K | -639.00K |
| NetPreferredStockIssuance | 0.00 | 0.00 | ||
| PreferredStockIssuance | 0.00 | 0.00 | ||
| NetCommonStockIssuance | 0.00 | 263.27M | 360.24M | 249.23M |
| CommonStockIssuance | 0.00 | 263.27M | 360.24M | 249.23M |
| NetIssuancePaymentsOfDebt | 32.53M | -3.99M | -352.35M | 81.66M |
| NetLongTermDebtIssuance | 32.53M | -3.99M | -352.35M | 81.66M |
| LongTermDebtPayments | -10.07M | -3.99M | -352.35M | -93.59M |
| LongTermDebtIssuance | 42.61M | 0.00 | 0.00 | 175.25M |
| InvestingCashFlow | -78.27M | -204.04M | -58.81M | -92.98M |
| CashFlowFromContinuingInvestingActivities | -78.27M | -204.04M | -58.81M | -92.98M |
| NetOtherInvestingChanges | 19.65M | 192.64M | ||
| NetInvestmentPurchaseAndSale | -91.53M | -382.04M | 0.00 | 0.00 |
| SaleOfInvestment | 353.74M | 443.55M | 0.00 | 0.00 |
| PurchaseOfInvestment | -445.27M | -825.59M | 0.00 | 0.00 |
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | ||
| PurchaseOfBusiness | 0.00 | 0.00 | ||
| NetIntangiblesPurchaseAndSale | -828.00K | -1.58M | -5.04M | -3.93M |
| PurchaseOfIntangibles | -3.93M | -2.98M | ||
| CapitalExpenditureReported | -5.56M | -13.06M | -53.77M | -89.06M |
| OperatingCashFlow | -244.63M | -87.26M | -713.97M | -415.94M |
| CashFlowFromContinuingOperatingActivities | -244.63M | -87.26M | -713.97M | -415.94M |
| ChangeInWorkingCapital | -887.71M | 48.48M | -376.84M | -361.15M |
| ChangeInOtherWorkingCapital | -622.94M | 67.11M | 350.87M | -1.05B |
| ChangeInPayablesAndAccruedExpense | -322.57M | -385.63M | -378.81M | 913.40M |
| ChangeInPayable | -322.57M | -385.63M | -378.81M | 913.40M |
| ChangeInAccountPayable | -322.57M | -385.63M | -378.81M | 913.40M |
| ChangeInInventory | -3.24M | 12.91M | -74.46M | -477.80M |
| ChangeInReceivables | 61.04M | 354.09M | -274.44M | 249.17M |
| ChangesInAccountReceivables | 61.04M | 354.09M | -274.44M | 249.17M |
| OtherNonCashItems | 5.76M | -18.05M | -929.00K | -3.80M |
| StockBasedCompensation | 36.02M | 48.15M | 85.36M | 130.30M |
| ProvisionandWriteOffofAssets | 1.95M | 20.97M | 72.20M | 447.60M |
| AssetImpairmentCharge | 102.72M | 4.13M | 10.08M | 0.00 |
| DepreciationAmortizationDepletion | 27.61M | 48.50M | 41.23M | 29.05M |
| DepreciationAndAmortization | 27.61M | 48.50M | 41.23M | 29.05M |
| OperatingGainsLosses | 28.71M | -51.95M | ||
| NetIncomeFromContinuingOperations | 440.30M | -187.50M | -545.06M | -657.94M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NVAX
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|